SB-616234

SB-616234 is a selective serotonin 5-HT 1B receptor antagonist.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

SB-616234 is a selective serotonin 5-HT 1B receptor antagonist. In terms of affinity, it shows 50-fold selectivity for the serotonin 5-HT 1B receptor over the serotonin 5-HT 1D receptor and greater than 100-fold selectivity for the serotonin 5-HT 1B receptor over other serotonin receptors. The drug is a silent antagonist of the serotonin 5-HT 1B receptor.

It dose-dependently increases serotonin levels in the dentate gyrus of the hippocampus in rodents via blockade of serotonin 5-HT 1B autoreceptors. In addition, it augments the increased serotonin levels induced by the selective serotonin reuptake inhibitor (SSRI) paroxetine in this brain area in rodents.

The drug produces antidepressant- and anxiolytic-like effects in rodents and anxiolytic-like effects in monkeys. It is orally active. SB-616234 was first described in the scientific literature by 2003.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1372707784 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.